Categories AlphaGraphs, Earnings, Health Care

ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The company also provided earnings guidance for fiscal 2022.

Abbvie Q2 2022 earnings infographics

Total revenues increased 5% year-over-year to $14.6 billion, aided by a strong performance by the immunology and neuroscience segments.

At $3.37 per share, adjusted net income was up 11% year-over-year. Unadjusted profit increased sharply to $924 million or $0.51 per share from $766 million or $0.42 per share in the second quarter of 2021.


Check this space to read management/analysts’ comments on AbbVie’s Q2 2022 earnings


“We delivered another strong quarter with substantial progress for our new products and indications. Importantly, Skyrizi and Rinvoq continued their impressive ramps and are on pace to deliver approximately $7.5 billion in combined annual sales, underscoring their significant potential,” said Richard A. Gonzalez, CEO of AbbVie.

Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top